Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 39 entries
Sorted by: Best Match Show Resources per page
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.

JCI insight

Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger AB.
PMID: 26973881
JCI Insight. 2016;1(2). doi: 10.1172/jci.insight.85841. Epub 2016 Feb 25.

Glioblastomas are highly infiltrated by diverse immune cells, including microglia, macrophages, and myeloid-derived suppressor cells (MDSCs). Understanding the mechanisms by which glioblastoma-associated myeloid cells (GAMs) undergo metamorphosis into tumor-supportive cells, characterizing the heterogeneity of immune cell phenotypes within glioblastoma...

Cite
Gabrusiewicz K, Rodriguez B, Wei J, et al. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight. 2016;1(2)doi: 10.1172/jci.insight.85841.
Gabrusiewicz, K., Rodriguez, B., Wei, J., Hashimoto, Y., Healy, L. M., Maiti, S. N., Thomas, G., Zhou, S., Wang, Q., Elakkad, A., Liebelt, B. D., Yaghi, N. K., Ezhilarasan, R., Huang, N., Weinberg, J. S., Prabhu, S. S., Rao, G., Sawaya, R., Langford, L. A., Bruner, J. M., Fuller, G. N., Bar-Or, A., Li, W., Colen, R. R., Curran, M. A., Bhat, K. P., Antel, J. P., Cooper, L. J., Sulman, E. P., & Heimberger, A. B. (2016). Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI insight, 1(2), . https://doi.org/10.1172/jci.insight.85841
Gabrusiewicz, Konrad, et al. "Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype." JCI insight vol. 1,2 (2016). doi: https://doi.org/10.1172/jci.insight.85841
Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger AB. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight. 2016;1(2). doi: 10.1172/jci.insight.85841. Epub 2016 Feb 25. PMID: 26973881; PMCID: PMC4784261.
Copy Download .nbib Format: NLM
Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation.

Cancer informatics

Rao A, Manyam G, Rao G, Jain R.
PMID: 27053917
Cancer Inform. 2016 Mar 29;15:29-33. doi: 10.4137/CIN.S33014. eCollection 2016.

Dynamic susceptibility contrast-enhanced magnetic resonance imaging is routinely used to provide hemodynamic assessment of brain tumors as a diagnostic as well as a prognostic tool. Recently, it was shown that the relative cerebral blood volume (rCBV), obtained from the...

Cite
Rao A, Manyam G, Rao G, et al. Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation. Cancer Inform. 2016;15:29-33doi: 10.4137/CIN.S33014.
Rao, A., Manyam, G., Rao, G., & Jain, R. (2016). Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation. Cancer informatics, 1529-33. https://doi.org/10.4137/CIN.S33014
Rao, Arvind, et al. "Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation." Cancer informatics vol. 15 (2016): 29-33. doi: https://doi.org/10.4137/CIN.S33014
Rao A, Manyam G, Rao G, Jain R. Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation. Cancer Inform. 2016 Mar 29;15:29-33. doi: 10.4137/CIN.S33014. eCollection 2016. PMID: 27053917; PMCID: PMC4814129.
Copy Download .nbib Format: NLM
APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death.

Oncotarget

Wang Y, Wu S, Zheng S, Wang S, Wali A, Ezhilarasan R, Sulman EP, Koul D, Alfred Yung WK.
PMID: 28903341
Oncotarget. 2017 Apr 21;8(33):54285-54296. doi: 10.18632/oncotarget.17348. eCollection 2017 Aug 15.

Genomic, transcriptional, and proteomic analyses of brain tumors reveal that subtypes differ in their pathway activity, progression, and response to therapy. We performed an expression profiling of Glioma Initiating Cells (GICs) and comparative analysis between different groups of GICs...

Cite
Wang Y, Wu S, Zheng S, et al. APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death. Oncotarget. 2017;8(33):54285-54296doi: 10.18632/oncotarget.17348.
Wang, Y., Wu, S., Zheng, S., Wang, S., Wali, A., Ezhilarasan, R., Sulman, E. P., Koul, D., & Alfred Yung, W. K. (2017). APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death. Oncotarget, 8(33), 54285-54296. https://doi.org/10.18632/oncotarget.17348
Wang, Yu, et al. "APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death." Oncotarget vol. 8,33 (2017): 54285-54296. doi: https://doi.org/10.18632/oncotarget.17348
Wang Y, Wu S, Zheng S, Wang S, Wali A, Ezhilarasan R, Sulman EP, Koul D, Alfred Yung WK. APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death. Oncotarget. 2017 Apr 21;8(33):54285-54296. doi: 10.18632/oncotarget.17348. eCollection 2017 Aug 15. PMID: 28903341; PMCID: PMC5589580.
Copy Download .nbib Format: NLM
An updated h-index measures both the primary and total scientific output of a researcher.

Discoveries (Craiova, Romania)

Bucur O, Almasan A, Zubarev R, Friedman M, Nicolson GL, Sumazin P, Leabu M, Nikolajczyk BS, Avram D, Kunej T, Calin GA, Godwin AK, Adami HO, Zaphiropoulos PG, Richardson DR, Schmitt-Ulms G, Westerblad H, Keniry M, Grau GE, Carbonetto S, Stan RV, Popa-Wagner A, Takhar K, Baron BW, Galardy PJ, Yang F, Data D, Fadare O, Yeo KJ, Gabreanu GR, Andrei S, Soare GR, Nelson MA, Liehn EA.
PMID: 26504901
Discoveries (Craiova). 2015 Jul-Sep;3(3). doi: 10.15190/d.2015.42. Epub 2015 Sep 30.

The growing interest in scientometry stems from ethical concerns related to the proper evaluation of scientific contributions of an author working in a hard science. In the absence of a consensus, institutions may use arbitrary methods for evaluating scientists...

Cite
Bucur O, Almasan A, Zubarev R, et al. An updated h-index measures both the primary and total scientific output of a researcher. Discoveries (Craiova). 2015;3(3)doi: 10.15190/d.2015.42.
Bucur, O., Almasan, A., Zubarev, R., Friedman, M., Nicolson, G. L., Sumazin, P., Leabu, M., Nikolajczyk, B. S., Avram, D., Kunej, T., Calin, G. A., Godwin, A. K., Adami, H. O., Zaphiropoulos, P. G., Richardson, D. R., Schmitt-Ulms, G., Westerblad, H., Keniry, M., Grau, G. E., Carbonetto, S., Stan, R. V., Popa-Wagner, A., Takhar, K., Baron, B. W., Galardy, P. J., Yang, F., Data, D., Fadare, O., Yeo, K. J., Gabreanu, G. R., Andrei, S., Soare, G. R., Nelson, M. A., & Liehn, E. A. (2015). An updated h-index measures both the primary and total scientific output of a researcher. Discoveries (Craiova, Romania), 3(3), . https://doi.org/10.15190/d.2015.42
Bucur, Octavian, et al. "An updated h-index measures both the primary and total scientific output of a researcher." Discoveries (Craiova, Romania) vol. 3,3 (2015). doi: https://doi.org/10.15190/d.2015.42
Bucur O, Almasan A, Zubarev R, Friedman M, Nicolson GL, Sumazin P, Leabu M, Nikolajczyk BS, Avram D, Kunej T, Calin GA, Godwin AK, Adami HO, Zaphiropoulos PG, Richardson DR, Schmitt-Ulms G, Westerblad H, Keniry M, Grau GE, Carbonetto S, Stan RV, Popa-Wagner A, Takhar K, Baron BW, Galardy PJ, Yang F, Data D, Fadare O, Yeo KJ, Gabreanu GR, Andrei S, Soare GR, Nelson MA, Liehn EA. An updated h-index measures both the primary and total scientific output of a researcher. Discoveries (Craiova). 2015 Jul-Sep;3(3). doi: 10.15190/d.2015.42. Epub 2015 Sep 30. PMID: 26504901; PMCID: PMC4617786.
Copy Download .nbib Format: NLM
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.

Clinical investigation

Jethwa K, Wei J, McEnery K, Heimberger AB.
PMID: 22468222
Clin Investig (Lond). 2011 Dec;1(12):1637-1650. doi: 10.4155/cli.11.159.

Glioblastoma (GB), the most common primary neoplasm of the CNS, remains universally fatal with standard therapies and has a mean overall survival time of only 14.6 months. Even in the most favorable situations most patients do not survive longer...

Cite
Jethwa K, Wei J, McEnery K, et al. miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma. Clin Investig (Lond). 2011;1(12):1637-1650doi: 10.4155/cli.11.159.
Jethwa, K., Wei, J., McEnery, K., & Heimberger, A. B. (2011). miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma. Clinical investigation, 1(12), 1637-1650. https://doi.org/10.4155/cli.11.159
Jethwa, Krishan, et al. "miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma." Clinical investigation vol. 1,12 (2011): 1637-1650. doi: https://doi.org/10.4155/cli.11.159
Jethwa K, Wei J, McEnery K, Heimberger AB. miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma. Clin Investig (Lond). 2011 Dec;1(12):1637-1650. doi: 10.4155/cli.11.159. PMID: 22468222; PMCID: PMC3314429.
Copy Download .nbib Format: NLM
Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.

Oncotarget

Narang S, Kim D, Aithala S, Heimberger AB, Ahmed S, Rao D, Rao G, Rao A.
PMID: 29254160
Oncotarget. 2017 Sep 05;8(60):101244-101254. doi: 10.18632/oncotarget.20643. eCollection 2017 Nov 24.

This study analyzed magnetic resonance imaging (MRI) scans of Glioblastoma (GB) patients to develop an imaging-derived predictive model for assessing the extent of intratumoral CD3 T-cell infiltration. Pre-surgical T1-weighted post-contrast and T2-weighted Fluid-Attenuated-Inversion-Recovery (FLAIR) MRI scans, with corresponding mRNA...

Cite
Narang S, Kim D, Aithala S, et al. Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma. Oncotarget. 2017;8(60):101244-101254doi: 10.18632/oncotarget.20643.
Narang, S., Kim, D., Aithala, S., Heimberger, A. B., Ahmed, S., Rao, D., Rao, G., & Rao, A. (2017). Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma. Oncotarget, 8(60), 101244-101254. https://doi.org/10.18632/oncotarget.20643
Narang, Shivali, et al. "Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma." Oncotarget vol. 8,60 (2017): 101244-101254. doi: https://doi.org/10.18632/oncotarget.20643
Narang S, Kim D, Aithala S, Heimberger AB, Ahmed S, Rao D, Rao G, Rao A. Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma. Oncotarget. 2017 Sep 05;8(60):101244-101254. doi: 10.18632/oncotarget.20643. eCollection 2017 Nov 24. PMID: 29254160; PMCID: PMC5731870.
Copy Download .nbib Format: NLM
Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma.

Cancer discovery

Puca F, Yu F, Bartolacci C, Pettazzoni P, Carugo A, Huang-Hobbs E, Liu J, Zanca C, Carbone F, Del Poggetto E, Gumin J, Dasgupta P, Seth S, Srinivasan S, Lang FF, Sulman EP, Lorenzi PL, Tan L, Shan M, Tolstyka ZP, Kachman M, Zhang L, Gao S, Deem AK, Genovese G, Scaglioni PP, Lyssiotis CA, Viale A, Draetta GF.
PMID: 34039636
Cancer Discov. 2021 Nov;11(11):2904-2923. doi: 10.1158/2159-8290.CD-20-1437. Epub 2021 May 26.

Glioblastoma (GBM) is highly resistant to chemotherapies, immune-based therapies, and targeted inhibitors. To identify novel drug targets, we screened orthotopically implanted, patient-derived glioblastoma sphere-forming cells using an RNAi library to probe essential tumor cell metabolic programs. This identified high...

Cite
Puca F, Yu F, Bartolacci C, et al. Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma. Cancer Discov. 2021;11(11):2904-2923doi: 10.1158/2159-8290.CD-20-1437.
Puca, F., Yu, F., Bartolacci, C., Pettazzoni, P., Carugo, A., Huang-Hobbs, E., Liu, J., Zanca, C., Carbone, F., Del Poggetto, E., Gumin, J., Dasgupta, P., Seth, S., Srinivasan, S., Lang, F. F., Sulman, E. P., Lorenzi, P. L., Tan, L., Shan, M., Tolstyka, Z. P., Kachman, M., Zhang, L., Gao, S., Deem, A. K., Genovese, G., Scaglioni, P. P., Lyssiotis, C. A., Viale, A., & Draetta, G. F. (2021). Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma. Cancer discovery, 11(11), 2904-2923. https://doi.org/10.1158/2159-8290.CD-20-1437
Puca, Francesca, et al. "Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma." Cancer discovery vol. 11,11 (2021): 2904-2923. doi: https://doi.org/10.1158/2159-8290.CD-20-1437
Puca F, Yu F, Bartolacci C, Pettazzoni P, Carugo A, Huang-Hobbs E, Liu J, Zanca C, Carbone F, Del Poggetto E, Gumin J, Dasgupta P, Seth S, Srinivasan S, Lang FF, Sulman EP, Lorenzi PL, Tan L, Shan M, Tolstyka ZP, Kachman M, Zhang L, Gao S, Deem AK, Genovese G, Scaglioni PP, Lyssiotis CA, Viale A, Draetta GF. Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma. Cancer Discov. 2021 Nov;11(11):2904-2923. doi: 10.1158/2159-8290.CD-20-1437. Epub 2021 May 26. PMID: 34039636.
Copy Download .nbib Format: NLM
Engineering the next generation of CAR-NK immunotherapies.

International journal of hematology

Biederstädt A, Rezvani K.
PMID: 34453686
Int J Hematol. 2021 Nov;114(5):554-571. doi: 10.1007/s12185-021-03209-4. Epub 2021 Aug 28.

Over the past few years, cellular immunotherapy has emerged as a novel treatment option for certain forms of hematologic malignancies with multiple CAR-T therapies now routinely administered in the clinic. The limitations of generating an autologous cell product and...

Cite
Biederstädt A, Rezvani K. Engineering the next generation of CAR-NK immunotherapies. Int J Hematol. 2021;114(5):554-571doi: 10.1007/s12185-021-03209-4.
Biederstädt, A., & Rezvani, K. (2021). Engineering the next generation of CAR-NK immunotherapies. International journal of hematology, 114(5), 554-571. https://doi.org/10.1007/s12185-021-03209-4
Biederstädt, Alexander, and Rezvani, Katayoun. "Engineering the next generation of CAR-NK immunotherapies." International journal of hematology vol. 114,5 (2021): 554-571. doi: https://doi.org/10.1007/s12185-021-03209-4
Biederstädt A, Rezvani K. Engineering the next generation of CAR-NK immunotherapies. Int J Hematol. 2021 Nov;114(5):554-571. doi: 10.1007/s12185-021-03209-4. Epub 2021 Aug 28. PMID: 34453686; PMCID: PMC8397867.
Copy Download .nbib Format: NLM
Computational immune infiltration analysis of pediatric high-grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location.

Computational and systems oncology

Bailey CP, Wang R, Figueroa M, Zhang S, Wang L, Chandra J.
PMID: 34723252
Comput Syst Oncol. 2021 Sep;1(3). doi: 10.1002/cso2.1016. Epub 2021 Mar 08.

Immunotherapy for cancer has moved from pre-clinical hypothesis to successful clinical application in the past 15 years. However, not all cancers have shown response rates in clinical trials for these new agents, high-grade gliomas in particular have proved exceedingly...

Cite
Bailey CP, Wang R, Figueroa M, et al. Computational immune infiltration analysis of pediatric high-grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location. Comput Syst Oncol. 2021;1(3)doi: 10.1002/cso2.1016.
Bailey, C. P., Wang, R., Figueroa, M., Zhang, S., Wang, L., & Chandra, J. (2021). Computational immune infiltration analysis of pediatric high-grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location. Computational and systems oncology, 1(3), . https://doi.org/10.1002/cso2.1016
Bailey, Cavan P, et al. "Computational immune infiltration analysis of pediatric high-grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location." Computational and systems oncology vol. 1,3 (2021). doi: https://doi.org/10.1002/cso2.1016
Bailey CP, Wang R, Figueroa M, Zhang S, Wang L, Chandra J. Computational immune infiltration analysis of pediatric high-grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location. Comput Syst Oncol. 2021 Sep;1(3). doi: 10.1002/cso2.1016. Epub 2021 Mar 08. PMID: 34723252; PMCID: PMC8553216.
Copy Download .nbib Format: NLM
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.

Oncotarget

Dong J, Park SY, Nguyen N, Ezhilarasan R, Martinez-Ledesma E, Wu S, Henry V, Piao Y, Tiao N, Brunell D, Stephan C, Verhaak R, Sulman E, Balasubramaniyan V, de Groot JF.
PMID: 29535822
Oncotarget. 2018 Jan 08;9(12):10497-10509. doi: 10.18632/oncotarget.24041. eCollection 2018 Feb 13.

BACKGROUND: Despite the availability of hundreds of cancer drugs, there is insufficient data on the efficacy of these drugs on the extremely heterogeneous tumor cell populations of glioblastoma (GBM).RESULTS: The PKIS of 357 compounds was initially evaluated in 15...

Cite
Dong J, Park SY, Nguyen N, et al. The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. Oncotarget. 2018;9(12):10497-10509doi: 10.18632/oncotarget.24041.
Dong, J., Park, S. Y., Nguyen, N., Ezhilarasan, R., Martinez-Ledesma, E., Wu, S., Henry, V., Piao, Y., Tiao, N., Brunell, D., Stephan, C., Verhaak, R., Sulman, E., Balasubramaniyan, V., & de Groot, J. F. (2018). The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. Oncotarget, 9(12), 10497-10509. https://doi.org/10.18632/oncotarget.24041
Dong, Jianwen, et al. "The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells." Oncotarget vol. 9,12 (2018): 10497-10509. doi: https://doi.org/10.18632/oncotarget.24041
Dong J, Park SY, Nguyen N, Ezhilarasan R, Martinez-Ledesma E, Wu S, Henry V, Piao Y, Tiao N, Brunell D, Stephan C, Verhaak R, Sulman E, Balasubramaniyan V, de Groot JF. The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. Oncotarget. 2018 Jan 08;9(12):10497-10509. doi: 10.18632/oncotarget.24041. eCollection 2018 Feb 13. PMID: 29535822; PMCID: PMC5828226.
Copy Download .nbib Format: NLM
Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.

Clinical cancer research : an official journal of the American Association for Cancer Research

Ott M, Kassab C, Marisetty A, Hashimoto Y, Wei J, Zamler D, Leu JS, Tomaszowski KH, Sabbagh A, Fang D, Gupta P, Priebe W, Zielinski RJ, Burks JK, Long JP, Kong LY, Fuller GN, DeGroot J, Sulman EP, Heimberger AB.
PMID: 32605912
Clin Cancer Res. 2020 Sep 15;26(18):4983-4994. doi: 10.1158/1078-0432.CCR-19-4092. Epub 2020 Jun 30.

PURPOSE: Patients with central nervous system (CNS) tumors are typically treated with radiotherapy, but this is not curative and results in the upregulation of phosphorylated STAT3 (p-STAT3), which drives invasion, angiogenesis, and immune suppression. Therefore, we investigated the combined...

Cite
Ott M, Kassab C, Marisetty A, et al. Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy. Clin Cancer Res. 2020;26(18):4983-4994doi: 10.1158/1078-0432.CCR-19-4092.
Ott, M., Kassab, C., Marisetty, A., Hashimoto, Y., Wei, J., Zamler, D., Leu, J. S., Tomaszowski, K. H., Sabbagh, A., Fang, D., Gupta, P., Priebe, W., Zielinski, R. J., Burks, J. K., Long, J. P., Kong, L. Y., Fuller, G. N., DeGroot, J., Sulman, E. P., & Heimberger, A. B. (2020). Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(18), 4983-4994. https://doi.org/10.1158/1078-0432.CCR-19-4092
Ott, Martina, et al. "Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26,18 (2020): 4983-4994. doi: https://doi.org/10.1158/1078-0432.CCR-19-4092
Ott M, Kassab C, Marisetty A, Hashimoto Y, Wei J, Zamler D, Leu JS, Tomaszowski KH, Sabbagh A, Fang D, Gupta P, Priebe W, Zielinski RJ, Burks JK, Long JP, Kong LY, Fuller GN, DeGroot J, Sulman EP, Heimberger AB. Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy. Clin Cancer Res. 2020 Sep 15;26(18):4983-4994. doi: 10.1158/1078-0432.CCR-19-4092. Epub 2020 Jun 30. PMID: 32605912.
Copy Download .nbib Format: NLM
Towards Real-time Metabolic Profiling of Cancer with Hyperpolarized Succinate.

Journal of molecular imaging & dynamics

Zacharias NM, McCullough CR, Wagner S, Sailasuta N, Chan HR, Lee Y, Hu J, Perman WH, Henneberg C, Ross BD, Bhattacharya P.
PMID: 27547490
J Mol Imaging Dyn. 2016 Jun;6(1). doi: 10.4172/2155-9937.1000123. Epub 2016 Jan 11.

PURPOSE: The energy-yielding mitochondrial Krebs cycle has been shown in many cancers and other diseases to be inhibited or mutated. In most cells, the Krebs cycle with oxidative phosphorylation generates approximately 90% of the adenosine triphosphate in the cell....

Cite
Zacharias NM, McCullough CR, Wagner S, et al. Towards Real-time Metabolic Profiling of Cancer with Hyperpolarized Succinate. J Mol Imaging Dyn. 2016;6(1)doi: 10.4172/2155-9937.1000123.
Zacharias, N. M., McCullough, C. R., Wagner, S., Sailasuta, N., Chan, H. R., Lee, Y., Hu, J., Perman, W. H., Henneberg, C., Ross, B. D., & Bhattacharya, P. (2016). Towards Real-time Metabolic Profiling of Cancer with Hyperpolarized Succinate. Journal of molecular imaging & dynamics, 6(1), . https://doi.org/10.4172/2155-9937.1000123
Zacharias, Niki M, et al. "Towards Real-time Metabolic Profiling of Cancer with Hyperpolarized Succinate." Journal of molecular imaging & dynamics vol. 6,1 (2016). doi: https://doi.org/10.4172/2155-9937.1000123
Zacharias NM, McCullough CR, Wagner S, Sailasuta N, Chan HR, Lee Y, Hu J, Perman WH, Henneberg C, Ross BD, Bhattacharya P. Towards Real-time Metabolic Profiling of Cancer with Hyperpolarized Succinate. J Mol Imaging Dyn. 2016 Jun;6(1). doi: 10.4172/2155-9937.1000123. Epub 2016 Jan 11. PMID: 27547490; PMCID: PMC4989923.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 39 entries